Zhejiang Haisen Pharmaceutical Co., Ltd. (001367)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
19. 15
+0.03
+0.1569%
¥
3.51B Market Cap
- P/E Ratio
0.11% Div Yield
1.6M Volume
- Eps
¥ 19.12
Previous Close Want to track 001367 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
001367 closed today higher at ¥19.15, an increase of 0.1569% from yesterday's close, completing a monthly increase of 3.9067% or ¥0.72. Over the past 12 months, 001367 stock lost -12.597%.
001367 is not paying dividends to its shareholders.
Zhejiang Haisen Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 20, 2025.
The company's stock is traded on one exchange.
001367 Chart
People also search for
Zhejiang Haisen Pharmaceutical Co., Ltd. (001367) FAQ
What is the stock price today?
The current price is ¥19.15.
On which exchange is it traded?
Zhejiang Haisen Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 001367.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.11%.
What is its market cap?
As of today, the market cap is 3.51B.
Has Zhejiang Haisen Pharmaceutical Co., Ltd. ever had a stock split?
Zhejiang Haisen Pharmaceutical Co., Ltd. had 2 splits and the recent split was on May 20, 2025.
Zhejiang Haisen Pharmaceutical Co., Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. Lin Ai CEO | XSHE Exchange | - ISIN |
| CN Country | 663 Employees | 13 May 2026 Last Dividend | 20 May 2025 Last Split | - IPO Date |
Overview
Zhejiang Haisen Pharmaceutical Co., Ltd. is a prominent entity in China's pharmaceutical industry, focusing on the research and development, production, and sale of chemical active pharmaceutical ingredients (APIs) and intermediates. Established in 1998, the company has solidified its position in the market by offering a vast range of products that cater to various medical needs. Its operational base in Dongyang, China, serves as the core from where it extends its services and products to a wide clientele, underscoring its pivotal role in the pharmaceutical sector within the country.
Products and Services
Zhejiang Haisen Pharmaceutical Co., Ltd.’s product offering is diverse, covering numerous therapeutic areas:
- Anti-Gastric Ulcer: The company manufactures APIs for treating gastric ulcers, providing relief to patients by inhibiting gastric acid secretion or protecting the stomach lining.
- Antilipemic Agent: These APIs are designed to lower lipid levels in the blood, assisting in the management and prevention of cardiovascular diseases.
- Antipyretic Analgesics: Offers relief from fever and pain, playing a critical role in symptomatic treatment.
- Antidepressant: The company provides active ingredients for antidepressants, aiding in the treatment of various forms of depression.
- Analgesic: These products offer pain relief, catering to both acute and chronic pain management.
- Antibacterial Agent: By developing APIs that target and inhibit bacterial growth, the company contributes to the treatment of bacterial infections.
- Antipyretic Analgesics: This category includes medications designed to reduce fever and alleviate pain, making it essential in treating symptoms of infections and other conditions.
- Histamines Drug: These APIs are used in medications that treat allergic reactions by blocking histamine receptors.
- Anticonvulsant: The company produces active pharmaceutical ingredients that help in managing and treating seizures, providing essential support for patients with epilepsy.
- Chemical Product for Intermediates and Food Additives: Beyond pharmaceuticals, Zhejiang Haisen Pharmaceutical Co., Ltd. offers chemical products used as intermediates in various industrial processes and food additives, highlighting their versatility and commitment to broadening their market reach.
Contact Information
Address: Liushi Street, Dongyang, China, 322104
Phone: 86 579 8676 8756
Website: https://www.haisenpharma.com
